Literature DB >> 12270704

Structure and inactivation of triosephosphate isomerase from Entamoeba histolytica.

Adela Rodríguez-Romero1, Alejandra Hernández-Santoyo, Luis del Pozo Yauner, Adrián Kornhauser, D Alejandro Fernández-Velasco.   

Abstract

Triosephosphate isomerase (TIM) has been proposed as a target for drug design. TIMs from several parasites have a cysteine residue at the dimer interface, whose derivatization with thiol-specific reagents induces enzyme inactivation and aggregation. TIMs lacking this residue, such as human TIM, are less affected. TIM from Entamoeba histolytica (EhTIM) has the interface cysteine residue and presents more than ten insertions when compared with the enzyme from other pathogens. To gain further insight into the role that interface residues play in the stability and reactivity of these enzymes, we determined the high-resolution structure and characterized the effect of methylmethane thiosulfonate (MMTS) on the activity and conformational properties of EhTIM. The structure of this enzyme was determined at 1.5A resolution using molecular replacement, observing that the dimer is not symmetric. EhTIM is completely inactivated by MMTS, and dissociated into stable monomers that possess considerable secondary structure. Structural and spectroscopic analysis of EhTIM and comparison with TIMs from other pathogens reveal that conformational rearrangements of the interface after dissociation, as well as intramonomeric contacts formed by the inserted residues, may contribute to the unusual stability of the derivatized EhTIM monomer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12270704     DOI: 10.1016/s0022-2836(02)00809-4

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  13 in total

1.  Triosephosphate isomerase of Taenia solium (TTPI): phage display and antibodies as tools for finding target regions to inhibit catalytic activity.

Authors:  Víctor Sanabria-Ayala; Iaraset Belmont; Landa Abraham
Journal:  Parasitol Res       Date:  2014-10-03       Impact factor: 2.289

Review 2.  Therapeutic targets for the treatment of microsporidiosis in humans.

Authors:  Bing Han; Louis M Weiss
Journal:  Expert Opin Ther Targets       Date:  2018-11-01       Impact factor: 6.902

3.  Structural Basis for Redox Regulation of Cytoplasmic and Chloroplastic Triosephosphate Isomerases from Arabidopsis thaliana.

Authors:  Laura M López-Castillo; Pedro Jiménez-Sandoval; Noe Baruch-Torres; Carlos H Trasviña-Arenas; Corina Díaz-Quezada; Samuel Lara-González; Robert Winkler; Luis G Brieba
Journal:  Front Plant Sci       Date:  2016-12-06       Impact factor: 5.753

4.  First characterization of a microsporidial triosephosphate isomerase and the biochemical mechanisms of its inactivation to propose a new druggable target.

Authors:  Itzhel García-Torres; Ignacio De la Mora-De la Mora; Gloria Hernández-Alcántara; Dora Molina-Ortiz; Silvia Caballero-Salazar; Alfonso Olivos-García; Gabriela Nava; Gabriel López-Velázquez; Sergio Enríquez-Flores
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

5.  UDP-galactose 4'-epimerase from the liver fluke, Fasciola hepatica: biochemical characterization of the enzyme and identification of inhibitors.

Authors:  Veronika L Zinsser; Steffen Lindert; Samantha Banford; Elizabeth M Hoey; Alan Trudgett; David J Timson
Journal:  Parasitology       Date:  2014-08-15       Impact factor: 3.234

6.  Virtual Screening of FDA-Approved Drugs against Triose Phosphate Isomerase from Entamoeba histolytica and Giardia lamblia Identifies Inhibitors of Their Trophozoite Growth Phase.

Authors:  Alfredo Juárez-Saldivar; Elizabeth Barbosa-Cabrera; Edgar E Lara-Ramírez; Alma D Paz-González; Ana V Martínez-Vázquez; Virgilio Bocanegra-García; Isidro Palos; Nuria E Campillo; Gildardo Rivera
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

7.  Perturbation of the dimer interface of triosephosphate isomerase and its effect on Trypanosoma cruzi.

Authors:  Vanesa Olivares-Illana; Adela Rodríguez-Romero; Ingeborg Becker; Miriam Berzunza; Juventino García; Ruy Pérez-Montfort; Nallely Cabrera; Francisco López-Calahorra; Marieta Tuena de Gómez-Puyou; Armando Gómez-Puyou
Journal:  PLoS Negl Trop Dis       Date:  2007-10-31

8.  Structural and functional perturbation of Giardia lamblia triosephosphate isomerase by modification of a non-catalytic, non-conserved region.

Authors:  Gloria Hernández-Alcántara; Alfredo Torres-Larios; Sergio Enríquez-Flores; Itzhel García-Torres; Adriana Castillo-Villanueva; Sara T Méndez; Ignacio de la Mora-de la Mora; Saúl Gómez-Manzo; Angélica Torres-Arroyo; Gabriel López-Velázquez; Horacio Reyes-Vivas; Jesús Oria-Hernández
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

Review 9.  Parasitic diarrheal disease: drug development and targets.

Authors:  Amir Azam; Mudasir N Peerzada; Kamal Ahmad
Journal:  Front Microbiol       Date:  2015-10-27       Impact factor: 5.640

10.  Novel and Selective Rhipicephalus microplus Triosephosphate Isomerase Inhibitors with Acaricidal Activity.

Authors:  Luiz Saramago; Helga Gomes; Elena Aguilera; Hugo Cerecetto; Mercedes González; Mauricio Cabrera; Maria Fernanda Alzugaray; Itabajara da Silva Vaz Junior; Rodrigo Nunes da Fonseca; Beatriz Aguirre-López; Nallely Cabrera; Ruy Pérez-Montfort; Alicia Merlino; Jorge Moraes; Guzmán Álvarez
Journal:  Vet Sci       Date:  2018-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.